These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20936626)

  • 1. Detecting data fabrication in clinical trials from cluster analysis perspective.
    Wu X; Carlsson M
    Pharm Stat; 2011; 10(3):257-64. PubMed ID: 20936626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
    Dallow NS; Leonov SL; Roger JH
    Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central statistical monitoring: detecting fraud in clinical trials.
    Pogue JM; Devereaux PJ; Thorlund K; Yusuf S
    Clin Trials; 2013 Apr; 10(2):225-35. PubMed ID: 23283577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the statistical power of different methods for the analysis of cluster randomization trials with binary outcomes.
    Austin PC
    Stat Med; 2007 Aug; 26(19):3550-65. PubMed ID: 17238238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting the number of clusters in n-way probabilistic clustering.
    He Z; Cichocki A; Xie S; Choi K
    IEEE Trans Pattern Anal Mach Intell; 2010 Nov; 32(11):2006-21. PubMed ID: 20847390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimators and confidence intervals for the proportion using binary auxiliary information with applications to pharmaceutical studies.
    Rueda M; Muñoz JF; Arcos A; Álvarez E; Martínez S
    J Biopharm Stat; 2011 May; 21(3):526-54. PubMed ID: 21442524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Under-smoothed kernel confidence intervals for the hazard ratio based on censored data.
    Tu D
    Biom J; 2007 Jun; 49(3):474-83. PubMed ID: 17623350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three methods for constructing parallel gatekeeping procedures in clinical trials.
    Dmitrienko A; Soulakova JN; Millen BA
    J Biopharm Stat; 2011 Jul; 21(4):768-86. PubMed ID: 21516568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hybrid Bayesian adaptive design for dose response trials.
    Chang M; Chow SC
    J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tests for inter-subject and total variabilities under crossover designs.
    Lee Y; Shao J; Chow SC; Wang H
    J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cluster pattern detection in spatial data based on Monte Carlo inference.
    Stoica RS; Gay E; Kretzschmar A
    Biom J; 2007 Aug; 49(4):505-19. PubMed ID: 17638287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression models for method comparison data.
    Dunn G
    J Biopharm Stat; 2007; 17(4):739-56. PubMed ID: 17613651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The analysis of small-sample multivariate data.
    Saranadasa H; Altan S
    J Biopharm Stat; 1998 Mar; 8(1):163-86. PubMed ID: 9547434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of confidence interval methods for the intraclass correlation coefficient in cluster randomized trials.
    Ukoumunne OC
    Stat Med; 2002 Dec; 21(24):3757-74. PubMed ID: 12483765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilcoxon-Mann-Whitney test: stratify or not?
    Qu Y; Zhao YD; Rahardja D
    J Biopharm Stat; 2008; 18(6):1103-11. PubMed ID: 18991110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trials.
    Proschan M; Follmann D
    Stat Med; 2008 Mar; 27(6):795-809. PubMed ID: 17594680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials simulation: a statistical approach.
    Westfall PH; Tsai K; Ogenstad S; Tomoiaga A; Moseley S; Lu Y
    J Biopharm Stat; 2008; 18(4):611-30. PubMed ID: 18607794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new paradigm for deriving and analyzing number needed to treat.
    Alemayehu D; Whalen E
    J Biopharm Stat; 2006; 16(2):181-92. PubMed ID: 16584066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.